See All Slides - tctmd.com

Slides

Presentation TCT 2013

Noninvasive Pressure Monitors (Sensible, Alere, Others)

Presenter: Philip Adamson

October 28, 2013

Presentation TCT 2013

The Case for Dedicated Bifurcation Stents; Device and Regulatory Landscape; and Anticipation of the Pivotal Tryton Results

Presenter: Martin Leon

October 28, 2013

Presentation TCT 2013

3D Bioprinting: The Unlimited Potential of Automated Tissue Engineering Processes

Presenter: Daniel B. Spoon

October 28, 2013

Presentation TCT 2013

Who Should Be Operated on for Functional MR? Guidelines and Practice (Surgical Perspectives)

Presenter: Michael Mack

October 28, 2013

Presentation TCT 2013

How to Get Started

Presenter: Adhir Shroff

October 28, 2013

Presentation TCT 2013

30-Day Readmission Criteria: How to Adapt and Reduce Your Risk

Presenter: Bruce Samuels

October 28, 2013

Presentation TCT 2013

Deep-dive Insights from the 5-year SYNTAX Left Main Results, and Relevance to 2013 Technology

Presenter: Marie-Claude Morice

October 28, 2013

Presentation TCT 2013

The Subintimal Antegrade Hypothesis Emerges: Rationale and Lessons from the Hybrid Registry

Presenter: Craig Thompson

October 28, 2013

Presentation TCT 2013

Do I Really Need Bioresorbable Scaffolds in the United States?

Presenter: Gregg Stone

October 28, 2013

Presentation TCT 2013

Yes! The Pathophysiology Dictates This and the Outcomes Data Are Clear

Presenter: Maurice Sarano

October 28, 2013

Advertisement

Slides

Noninvasive Pressure Monitors (Sensible, Alere, Others)

The Case for Dedicated Bifurcation Stents; Device and Regulatory Landscape; and Anticipation of the Pivotal Tryton Results

3D Bioprinting: The Unlimited Potential of Automated Tissue Engineering Processes

Who Should Be Operated on for Functional MR? Guidelines and Practice (Surgical Perspectives)

How to Get Started

30-Day Readmission Criteria: How to Adapt and Reduce Your Risk

Deep-dive Insights from the 5-year SYNTAX Left Main Results, and Relevance to 2013 Technology

The Subintimal Antegrade Hypothesis Emerges: Rationale and Lessons from the Hybrid Registry

Do I Really Need Bioresorbable Scaffolds in the United States?

Yes! The Pathophysiology Dictates This and the Outcomes Data Are Clear

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content